Healthcare Value Capital, LLC

13F Filings History

Latest 13F report
Q3 2021 - Nov 15, 2021
Value $
$38.5M
Signature - Title
Thomas DesChamps - Managing Director, Portfolio Manager
Location
Woodcliff Lake, NJ
Summary
This page shows a list of all the recent 13F filings made by Healthcare Value Capital, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Healthcare Value Capital, LLC reported 18 stock holdings with total value $38.5M as of Q3 2021. Top holdings included GILD, GSK, PFE, ALKS, and AMYT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2021 18 $38.5M +$2.44M -$7.66M -$5.22M GILD, GSK, PFE, ALKS, AMYT 13F-HR 11/12/2021, 07:56 PM
Q2 2021 18 $46.2M +$9.13M -$1.3M +$7.83M GILD, GSK, PFE, ALKS, BMY 13F-HR 8/16/2021, 11:28 AM
Q1 2021 18 $39.2M +$23.7M -$12.8M +$10.8M GILD, PFE, GSK, CLVSQ, VYNE 13F-HR 5/17/2021, 08:27 AM
Q4 2020 13 $25.9M +$736K -$4.65M -$3.92M ABBV, GSK, VYNE, GILD, TYME 13F-HR 2/16/2021, 01:48 PM
Q3 2020 13 $27.3M +$5.13M -$9.37M -$4.24M GSK, JAZZ, GILD, ABBV, VYNE 13F-HR 11/16/2020, 09:48 AM
Q2 2020 15 $34.7M +$3.81M -$18M -$14.2M GSK, GILD, SPXU, MNLO, TYME 13F-HR 8/14/2020, 09:13 AM
Q1 2020 18 $47.2M +$25.3M -$6.15M +$19.1M ABBV, GSK, GILD, SPXU, CAH 13F-HR 5/15/2020, 08:47 AM
Q4 2019 13 $32M +$803K -$5.93M -$5.12M GSK, GILD, ABBV, CVS, TYME 13F-HR 2/14/2020, 02:02 PM
Q3 2019 16 $32.5M +$16.8M -$3.48M +$13.3M GILD, GSK, ABBV, CVS, WBA 13F-HR 11/14/2019, 11:56 AM
Q2 2019 8 $21.5M +$7.34M -$5.15M +$2.19M GSK, GILD, TYME, GNLN, PFE 13F-HR 8/14/2019, 10:46 AM
Q1 2019 8 $21.8M +$6.92M -$7.33M -$411K AGN, GSK, TYME, GILD, VKTX 13F-HR 5/14/2019, 05:09 PM
Q4 2018 8 $24.8M +$678K -$15.5M -$14.8M TYME, LAB, GSK, BIS, AGN 13F-HR 2/13/2019, 12:01 PM
Q3 2018 11 $41.1M +$782K -$1.71M -$925K GILD, AMRN, TYME, GSK, AGN 13F-HR 11/13/2018, 05:49 PM
Q2 2018 11 $34.7M +$10M $0 +$10M GILD, TYME, NVLNF, GSK, AGN 13F-HR 8/7/2018, 04:13 PM
Q1 2018 8 $23M +$2.94M $0 +$2.94M GILD, TYME, NVLNF, LAB, GSK 13F-HR 4/27/2018, 05:13 PM
Q4 2017 8 $28.5M +$848K -$13M -$12.1M TYME, GILD, NVLNF, LAB, AMRN 13F-HR 1/23/2018, 01:05 PM
Q3 2017 9 $42.1M +$14.2M -$6.14M +$8.07M TYME, PFE, NVLNF, GILD, DEPO 13F-HR 11/13/2017, 10:23 AM
Q2 2017 9 $37.3M +$3.1M -$7.12M -$4.02M PFE, NVLNF, DEPO, GILD, AGN 13F-HR 8/10/2017, 03:10 PM
Q1 2017 12 $43.1M +$1.6M -$15.3M -$13.7M NVLNF, PFE, GILD, DEPO, AMRI 13F-HR 5/12/2017, 03:30 PM
Q4 2016 14 $58.3M +$22.5M -$14.9M +$7.61M ANIP, PFE, NVLNF, DEPO, AMRI 13F-HR 2/10/2017, 10:53 AM
Q3 2016 15 $54.1M +$3.41M -$14.8M -$11.3M ANIP, DEPO, PFE, DGX, AMRI 13F-HR 11/10/2016, 03:02 PM
Q2 2016 14 $54.6M +$1.57M -$7.08M -$5.52M ANIP, DEPO, PFE, DGX, AORT 13F-HR 8/15/2016, 12:18 PM
Q1 2016 16 $49.3M +$6.82M -$1.41M +$5.4M ANIP, AMRI, PFE, DEPO, DGX 13F-HR 5/16/2016, 12:13 PM
Q4 2015 15 $53.6M +$4.29M -$11M -$6.68M ANIP, AMRI, QLTI, PFE, DGX 13F-HR 2/16/2016, 02:53 PM
Q3 2015 20 $56M +$11.3M -$9.68M +$1.58M ANIP, AMRI, AZN, QLTI, PFE 13F-HR 11/16/2015, 10:57 AM
Q2 2015 22 $69.2M +$22.1M -$20.7M +$1.37M AMRI, QLTI, ANIP, AZN, PFE 13F-HR 8/14/2015, 09:47 AM
Q1 2015 25 $67M +$16.3M -$2.72M +$13.6M AMRI, TWM, AZN, TEVA, DGX 13F-HR 5/14/2015, 02:57 PM
Q4 2014 19 $49.4M +$10.1M -$27.8M -$17.7M AMRI, AZN, TEVA, DGX, PFE 13F-HR 2/13/2015, 01:13 PM
Q3 2014 23 $69.3M +$26.6M -$20M +$6.62M TWM, AMRI, ANIP, B108PS, TEVA 13F-HR 11/13/2014, 11:15 AM
Q2 2014 25 $64.8M +$15.3M -$10.8M +$4.5M AMRI, AZN, ANIP, TEVA, AUXL 13F-HR 8/13/2014, 04:14 PM
Q1 2014 27 $62.7M +$24.5M -$35.7M -$11.2M AMRI, TEVA, AUXL, DGX, MRK 13F-HR 5/13/2014, 12:24 PM
Q4 2013 23 $61.6M $0 $0 ANIP, SUPN, AUXL, AZN, FRX 13F-HR 2/13/2014, 09:15 AM